How One Biopharma Company Overcame Trial Failure - Clinical Leader
... AI in this and future trials. Clinical Leader: Take us back to the initial failure of the PolyPid's SHIELD I Phase 3 trial for D-PLEX100 in 2022.
Read the original at Clinical Leader ↗
- Topics
- Healthcare
- Tracked via
- “AI Falures”